Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Michl

Showing results (121-130 of 151) with videos related to

Pageof 16
Sort By:
Cancer Research|October 16, 2003
Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancerPatrick Michl, Claudia Barth, Malte Buchholz, et al.
Plos One|December 13, 2017
Clinicopathological hallmarks and biomarkers of colorectal neuroendocrine neoplasmsAlexander Koenig, Sebastian Krug, Daniela Mueller, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 25, 2019
Serum levels of advanced glycation end products and their receptors sRAGE and Galectin-3 in chronic pancreatitisRichard Böhme, Carla Becker, Bettina Keil, et al.
Cancers|February 15, 2022
The Patient's Point of View: COVID-19 and Neuroendocrine Tumor DiseaseSebastian Krug, Maryam Khosravian, Julia Weissbach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2025
Activity and Safety of Avelumab in High-Grade Neuroendocrine Tumors and Poorly Differentiated Neuroendocrine Carcinomas Progressive after Chemotherapy (AveNEC Trial)Christian Fottner, Leonidas Apostolidis, Sebastian Krug, et al.
Orphanet Journal of Rare Diseases|January 22, 2025
A comparative analysis in monitoring 24-hour urinary copper in wilson disease: sampling on or off treatment?Isabelle Mohr, Patrick Lamade, Christophe Weber, et al.
BMC Cancer|January 17, 2016
DocOx (AIO-PK0106): a phase II trial of docetaxel and oxaliplatin as a second line systemic therapy in patients with advanced pancreatic ductal adenocarcinomaThomas J Ettrich, Lukas Perkhofer, Goetz von Wichert, et al.
Targeted Oncology|February 28, 2024
Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-World DataAlexander Olkus, Aurelie Tomczak, Anne Katrin Berger, et al.
Plos One|February 7, 2022
Pleuropulmonary pathologies in the early phase of acute pancreatitis correlate with disease severityIna Luiken, Stephan Eisenmann, Jakob Garbe, et al.
Gastroenterology|August 17, 2014
Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in micePatrick C Hermann, Patricia Sancho, Marta Cañamero, et al.
Pageof 16

Showing results (121-130 of 151) with videos related to

Sort By:
Pageof 16
Cancer Research|October 16, 2003
Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancerPatrick Michl, Claudia Barth, Malte Buchholz, et al.
Plos One|December 13, 2017
Clinicopathological hallmarks and biomarkers of colorectal neuroendocrine neoplasmsAlexander Koenig, Sebastian Krug, Daniela Mueller, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 25, 2019
Serum levels of advanced glycation end products and their receptors sRAGE and Galectin-3 in chronic pancreatitisRichard Böhme, Carla Becker, Bettina Keil, et al.
Cancers|February 15, 2022
The Patient's Point of View: COVID-19 and Neuroendocrine Tumor DiseaseSebastian Krug, Maryam Khosravian, Julia Weissbach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2025
Activity and Safety of Avelumab in High-Grade Neuroendocrine Tumors and Poorly Differentiated Neuroendocrine Carcinomas Progressive after Chemotherapy (AveNEC Trial)Christian Fottner, Leonidas Apostolidis, Sebastian Krug, et al.
Orphanet Journal of Rare Diseases|January 22, 2025
A comparative analysis in monitoring 24-hour urinary copper in wilson disease: sampling on or off treatment?Isabelle Mohr, Patrick Lamade, Christophe Weber, et al.
BMC Cancer|January 17, 2016
DocOx (AIO-PK0106): a phase II trial of docetaxel and oxaliplatin as a second line systemic therapy in patients with advanced pancreatic ductal adenocarcinomaThomas J Ettrich, Lukas Perkhofer, Goetz von Wichert, et al.
Targeted Oncology|February 28, 2024
Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-World DataAlexander Olkus, Aurelie Tomczak, Anne Katrin Berger, et al.
Plos One|February 7, 2022
Pleuropulmonary pathologies in the early phase of acute pancreatitis correlate with disease severityIna Luiken, Stephan Eisenmann, Jakob Garbe, et al.
Gastroenterology|August 17, 2014
Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in micePatrick C Hermann, Patricia Sancho, Marta Cañamero, et al.
Pageof 16